Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 11:24 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1513–1536 of 79,317 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: 2 Clear all

Conditions: Ventral Hernia
Interventions: Not listed
Lead sponsor: AdventHealth; Other
Eligibility: 18 Years to 89 Years
Enrollment: 61 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Celebration, Florida

Conditions: Pain Measurement
Interventions: Alfentanil, Propranolol, Placebo; Drug
Lead sponsor: Martin Angst; Other
Eligibility: Not listed
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010
U.S. locations: 1
States / cities: Stanford, California

Conditions: Developmental Delay
Interventions: Bright By Three (BB3), Texts for Child Safety (TCS); Behavioral
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 12 Months to 15 Months
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Prostate Cancer Metastatic Disease
Interventions: Hypocaloric anti-inflammatory diet; Behavioral
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years and older · Male only
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 2
States / cities: Los Angeles, California

Conditions: Breast Cancer
Interventions: Epidiferphane, Taxane Chemotherapy; Drug
Lead sponsor: University of Florida; Other
Eligibility: 18 Years to 99 Years
Enrollment: 74 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Dystonia, Drug Induced Dystonia, Parkinson Disease, Essential Tremor, Dyskinesias, Myoclonus, Tic Disorders, Torticollis, Ulnar Nerve Entrapment, Temporomandibular Joint Disorders, Dysphonia
Interventions: DystoniaNet-based diagnosis of isolated dystonia; Diagnostic Test
Lead sponsor: Massachusetts Eye and Ear Infirmary; Other
Eligibility: Not listed
Enrollment: 1,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2028
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Sickle Cell Disease
Interventions: Hematopoietic Stem Cell Transplantation, CliniMACS, See intervention description; Procedure · Device · Drug
Lead sponsor: St. Jude Children's Research Hospital; Other
Eligibility: 2 Years to 16 Years
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2009
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Plagiocephaly, Nonsynostotic
Interventions: Serkel 3D CRO; Device
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 4 Months to 18 Months
Enrollment: 18 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Cardiovascular Disease
Interventions: ticagrelor, prasugrel, Placebo; Drug
Lead sponsor: Yochai Birnbaum; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 3
States / cities: Houston, Texas

Conditions: Vasectomy Reversal
Interventions: Prednisone; Drug
Lead sponsor: Charitable Union for the Research and Education of Peyronie's Disease; Other
Eligibility: 18 Years to 65 Years · Male only
Enrollment: 75 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Orem, Utah

Conditions: Diabetes Mellitus, Type 2
Interventions: iPATH implementation approach; Other
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 119,680 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2028
U.S. locations: 3
States / cities: Stanford, California • Boston, Massachusetts • Columbus, Ohio

Conditions: Stroke, Physical Disability
Interventions: real stimulation, No stimulation; Device
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years and older
Enrollment: 61 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Pneumonia
Interventions: Experimental Oral Nutritional Supplement; Other
Lead sponsor: Abbott Nutrition; Industry
Eligibility: 55 Years and older
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 12
States / cities: Mobile, Alabama • Chicago, Illinois • Springfield, Illinois + 9 more

Conditions: Intracranial Pressure Increase
Interventions: Video ophthalmoscope; Device
Lead sponsor: University of Minnesota; Other
Eligibility: 4 Years and older
Enrollment: 90 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2030
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Severe Eosinophilic Chronic Sinusitis Without Nasal Polyposis
Interventions: Dupilumab 300 MG/2 ML Subcutaneous Solution [DUPIXENT], Placebo; Drug · Other
Lead sponsor: University of South Florida; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Ectonucleotide Pyrophosphatase/phosphodiesterase1 Deficiency, ATP-Binding Cassette Subfamily C Member 6 Deficiency, Generalized Arterial Calcification of Infancy, Autosomal Recessive Hypophosphatemic Rickets, PXE (Pseudoxanthoma Elasticum)
Interventions: Not listed
Lead sponsor: Inozyme Pharma; Industry
Eligibility: 1 Day and older
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2025
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Dietary Modification
Interventions: Tart cherry Juice, High-fat meal, Exercise; Dietary Supplement · Other
Lead sponsor: University of Georgia; Other
Eligibility: 18 Years to 30 Years · Male only
Enrollment: 13 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Athens, Georgia

Conditions: CD19 Positive, Mixed Phenotype Acute Leukemia (MPAL)
Interventions: Subcutaneous Blinatumomab; Drug
Lead sponsor: West Virginia University; Other
Eligibility: 18 Years and older
Enrollment: 78 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: Morgantown, West Virginia

Conditions: Papilloma Viral Infection
Interventions: Not listed
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 9 Years to 17 Years · Female only
Enrollment: 1,321 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2014
U.S. locations: 7
States / cities: Tucker, Georgia • Baltimore, Maryland • Kansas City, Missouri + 4 more

Conditions: Physiological Stress
Interventions: Virtual- reality active shooter drill; Device
Lead sponsor: Texas State University; Other
Eligibility: 18 Years to 39 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: San Marcos, Texas

Conditions: Interpersonal Violence, Structural Violence
Interventions: Active Case Management, Treatment as usual; Other
Lead sponsor: Kevin Borrup; Other
Eligibility: 8 Years to 17 Years
Enrollment: 225 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Hartford, Connecticut

Conditions: Drug Resistant Epilepsy, Drop Seizures, Generalized Tonic Clonic Seizure, Complex Partial Seizure, Fall Due to Seizure
Interventions: Hövding inflatable helmet; Device
Lead sponsor: Michael A. Gelfand, MD, PhD; Other
Eligibility: 18 Years to 60 Years
Enrollment: 9 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Insomnia
Interventions: Sip2Sleep: Montmorency Cherry and Apocynum Venetum; Other
Lead sponsor: Lakshmi Nutraceuticals LLC; Industry
Eligibility: 18 Years and older
Enrollment: 77 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023
U.S. locations: 1
States / cities: West Hollywood, California

Conditions: Visual Acuity, Comfort, Overall Vision
Interventions: senofilcon A; Device
Lead sponsor: Johnson & Johnson Vision Care, Inc.; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 136 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013
U.S. locations: 4
States / cities: Jacksonville, Florida • Bloomington, Illinois • Pittsburg, Kansas + 1 more

Search by objective public record fields.

Prevena Incision Management System Wound Care

Evaluation of Propranolol's Effect on Pain and Inflammation.

Bright by Three (BB3) Effectiveness Study

Role of Race in Nutritional Approach in Men on ADT

Pharmacokinetics and Safety of Epidiferphane and Taxanes in Breast Cancer Patients

Clinical Validation of DystoniaNet Deep Learning Platform for Diagnosis of Isolated Dystonia

Haploidentical Stem Cell Transplant for Patients With Sickle Cell Disease and Prior Stroke or Abnormal Transcranial Ultrasound

Observe the Effects of the Serkel Cranial Remolding Orthosis on Infants With Deformational Plagiocephaly

Ticagrelor vs. Prasugrel Effects on Infarct Size

The Impact of Prednisone on Semen Parameters and Pregnancy Rates Post Vasectomy Reversal

Implementing Scalable, PAtient-centered, Team-based, Technology-enabled Care for Adults With Type 2 Diabetes (iPATH)

Concomitant Sensory Stimulation During Therapy to Enhance Hand Functional Recovery Post Stroke

Evaluation of an Oral Nutritional Supplement in Older Hospitalized Patients

Non-Invasive and Non-Contact Intracranial Pressure Waveform Recording Using Dynamic Video Ophthalmoscopy

Dupilumab Severe Eosinophilic Chronic Sinusitis Without Nasal Polyposis

Natural History Study: ENPP1 Deficiency or the Early-Onset Form of ABCC6 Deficiency

Antioxidant Responses to Exercise and Cherry Consumption

Subcutaneous Blinatumomab for Treatment of Adult Patients With CD19-Positive Mixed Phenotype Acute Leukemia (MPAL)

Immunogenicity of Off-Schedule Dosing of HPV Vaccine

Impact of Breathing Interventions on Stress Markers

Strengthening the Connections to Opportunities for Prevention Engagement

Novel Helmet Design in Patients With Seizures

Combined Effects of Prunus Cerasus and Apocynum Venetum On Sleep and Anxiety in Adults With Insomnia

Senofilcon A Investigational Manufacturing Process